Revenue: US$84.5m (down 55% from 3Q 2023). Net loss: US$121.3m (loss narrowed by 7.2% from 3Q 2023). US$0.76 loss per share ...

Novavax incurred a third-quarter 2024 loss of 76 cents per share, narrower than the Zacks Consensus Estimate of a loss of 87 cents. In the year-ago quarter, the company reported a loss of $1.26 per ...

Mamtani covers the Healthcare sector, focusing on stocks such as Cytokinetics, Novavax, and Harrow Health. According to TipRanks, Mamtani has an average return of -10.8% and a 28.60% success rate on ...

Health-care companies slipped as vaccine makers remained under pressure. Shares of Novavax plunged by 8%, compounding losses in the wake of the vaccine developer's earnings report. Rival Moderna lost ...

The Dow Jones Industrial Average fell 382.15 points, or 0.86%, to 43,910.98, the S&P 500 lost 17.36 points, or 0.29%, to ...

TD Cowen analyst Brendan Smith maintained a Buy rating on Passage Bio (PASG – Research Report) today. The company’s shares opened ...

Inovio Pharmaceuticals Inc.-3.88% $128.52M ...

BANGKOK—The Chinese Consulate in Myanmar’s second-largest city has been slightly damaged by an explosive device, but there were no casualties, the military, independent media and a city resident said ...

The study was based on outcomes seen among essential workers with COVID-19 infection from June 2021 to September 2022.

A total of 438 confirmed and probable cases of meningococcal disease were reported in 2023, the most US cases reported since ...